Allergy Diagnostics Market Overview and Introduction

The global allergy diagnostic market is estimated to be over US$ 3 bn in 2018. It is anticipated to grow at a CAGR of 9.8% from 2019 to 2030.

Allergy is a chronic condition in which the immune system of patient reacts with allergens in the environment such as insects, pollen, foods and some medicines. Allergist diagnoses allergies with the help of skin testing or blood testing. Identification of the patient’s affectability to common inhalants can be done by both blood and skin allergy tests. Allergy tests play an important role in providing reliable, proper and accurate results that reveal clearer scenario of what is the reason for allergic diseases, or what exactly is causing it.

The market is driven by high incidence and prevalence of allergic diseases. Around 45-50 million people in the U.S. are suffering from allergies or asthma. Moreover, increasing pollution levels in the environment are responsible for the diseases such as rhinitis, eczema, asthma and epigenetic regulation. However, allergic treatment and diagnosis requires high cost. Therefore, the high price of allergy diagnostics can restrain the growth of this market.

The market is segmented by product & services, allergen type, test type and end user.

Allergy Diagnostics Market by Product & Services

On the basis of product & services, the market is segmented into assay kits, consumables, instruments and services. Instruments are further divided into immunoassay analyzers, ELISA analyzers, luminometers and other instruments. The assay kits segment is anticipated to account for the largest share in the global allergy diagnostics market.

Allergy Diagnostics Market by Types

On the basis of allergen type, the market is segmented into drug allergens, inhaled allergens, food allergens and other allergens. The inhaled allergens segment is anticipated to hold the largest share of this market. Based on the test type, market is classified into in vivo test and in vitro test.

Allergy Diagnostics Market by End Users

In terms of end users, the market is segmented into academic research institutes, diagnostic laboratories, hospitals and other end users. The diagnostic laboratories segment is expected to lead the allergy diagnostic market during the forecast period.

Allergy Diagnostics Market by Regions

The market can be segmented into North America, Europe, Asia Pacific and Rest of World (ROW). North America dominated the market of allergy diagnostics, followed by Europe and Asia Pacific. North America will continue to dominate the market in the forecast period owing to factors such as better medical infrastructure and high awareness towards allergies. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at India, China and Japan. Factors such as increasing population, continuously growing economy and increasing awareness is expected to aid the growth of the allergy diagnostics market in this region.

Allergy Diagnostics Market Prominent Players

The prominent players in the allergy diagnostics market are Thermo Fisher Scientific Inc., Omega Diagnostics Group PLC, Hitachi Chemical Co., Ltd., R-Biopharm AG, Stallergenes Greer, Siemens AG, Danaher Corporation, Biomérieux SA, Hycor Biomedical, Inc., Lincoln Diagnostics, Inc. among others.